Hi @johnrap
Its been a quite couple of months in NSB land thats for sure, so this is some welcome news. For those who haven't already, worth revisiting the HealthKick Podcast: NSB brings new solutions to medicine’s most stubborn eye problems - from 14:12 there is approx. 3 mins of chat on the post Covid fibrosis arm of the business. This podcast was by the ex-Charmain in Feb this year. He mentions that after safety phase 1 in humans they can go into post Covid fibrosis patients... so still a while to go on this one yet perhaps. But lets see what they have to tell us with the TH
The pre-clinical data from Emtinb has all the hallmarks of a breakthrough drug. I think the market wants to see us get this thing into humans. Looking forward to trials beginning and will play the waiting game until Q1/Q2 next year when Glaucoma studies will hopefully return a banger of a result. Until then, happy to leave this one on hold while the company goes through the motions of making all of this happen
Cheers and GLTAH
- Forums
- ASX - By Stock
- NSB
- Ann: Results from Pulmonary Studies
Ann: Results from Pulmonary Studies, page-57
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.639M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 465000 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 274977 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 465000 | 0.036 |
3 | 210000 | 0.035 |
1 | 100000 | 0.034 |
5 | 290133 | 0.033 |
1 | 200000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 274977 | 3 |
0.042 | 178333 | 3 |
0.043 | 240000 | 2 |
0.044 | 324875 | 2 |
0.045 | 20000 | 1 |
Last trade - 16.12pm 10/10/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online